TPSi Opens Dedicated Oncology Unit

In the US, The Planning Shop International (TPSi) has launched a new Oncology Business Unit (OBU), staffed by a team of market research professionals who are specialists in both the oncology therapeutic area and its associated brands.

TPSi, which was established in 1987, specializes in market research services for the pharmaceutical industry from its offices in London, Brussels and Philadelphia.

Last year, the company launched the FutureThinker panel, offering access to clinicians who are 'Key Opinion Leaders' in the US, UK, Germany, France, Italy and Spain.

Leading the new OBU is Kelly Price, who has spent eight years working in syndicated and customized oncology research in Japan, China, elsewhere in Asia Pacific, and most recently in the United States.

Most recently, Price worked as Head of Synovate Healthcare's Asia Pacific Oncology Monitors.

TPSi OBU has been established by North America President Sherry Fox, who comments: 'We recognized the need for a dedicated division focused on oncology, so we set out to find a leader who would contribute the necessary expertise. Many of our clients are specifically asking for this level of oncology knowledge, which combined with our brand strategy experience will provide a complete solution to oncology marketing research needs.'

Web site: www.planningshopintl.com .

All articles 2006-23 written and edited by Mel Crowther and/or Nick Thomas, 2024- by Nick Thomas, unless otherwise stated.

• Planning Shop International Ltd, The
• All news